Accessibility Menu
Elekta Ab (publ) logo

Elekta Ab (publ)(OTC) EKTAY

Market Cap$1.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+161%
5 Year-59%
1 Year+9%
1 Month-2%
$5.05
-0.32%
-0.02Today
Elekta Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 5.052026-07-31
Elekta Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.84%USD 4.772026-07-24
1 month-2.15%USD 5.162026-07-01
3 month-13.32%USD 5.832026-05-01
Year to date-15.53%USD 5.982025-12-31
1 year+9.1%USD 4.632025-07-31
3 year-28.53%USD 7.062023-08-01
5 year-58.55%USD 12.182021-07-30
Since inception+160.79%USD 1.942008-12-12

Elekta Ab (publ) Financials at a Glance

Market Cap

$1.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 16.55B

Net Income (TTM)

-SEK 521.04M

EPS (TTM)

-$0.15

P/E Ratio

-33.37

Dividend

$0.26

Beta (Volatility)

0.74 (Low)

Price

$5.05

Volume

11,107

Open

$5.04

Previous Close

$5.05

Daily Range

$5.00 - $5.05

52-Week Range

$4.35 - $6.93

Estimated Earnings Date

Aug 27, 2026

EKTAY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elekta Ab (publ)

Elekta AB (publ) is a global medical technology company focused on developing advanced clinical solutions for cancer and brain disorders. The company offers a comprehensive portfolio of innovative radiotherapy systems and treatment management software, enhancing patient care and outcomes.

Products and Services
  • Elekta Unity MR-Linac for precision radiotherapy
  • Elekta Harmony linear accelerator for diverse patient needs
  • Comprehensive treatment management software solutions
Growth Outlook
  • Increasing demand for cancer treatment technologies drives growth potential
  • Expansion into emerging markets enhances revenue opportunities
  • Continuous innovation in product offerings supports competitive advantage
Financial Highlights
  • Recent quarterly revenue of 4.77 billion SEK, showing strong market presence
  • Trailing twelve months (TTM) gross profit margin at 37.39%, indicating operational efficiency
  • Dividend yield of 5.11%, reflecting commitment to shareholder returns
Elekta AB (publ) operates in the medical instruments and supplies industry, providing essential solutions for oncology and neurosurgery. The company's innovative products, such as the Elekta Unity MR-Linac and Elekta Harmony linear accelerator, are designed to meet the growing demand for advanced cancer treatment technologies. With a focus on expanding into emerging markets and continuous product innovation, Elekta is well-positioned for future growth. Recent financial performance highlights include a robust quarterly revenue and a solid gross profit margin, underscoring the company's operational efficiency. Additionally, a competitive dividend yield reflects Elekta's commitment to delivering value to shareholders.
AI Generated • Jul 25, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

4,102

CEO

Jakob Just-Bomholt

Website

www.elekta.com

Headquarters

Stockholm, SD 103 93, SE

EKTAY Financials

Key Financial Metrics (TTM)

Gross Margin

37.39%

Operating Margin

5.29%

Net Income Margin

-3.10%

Return on Equity

-6.37%

Return on Capital

2.96%

Return on Assets

-1.93%

Earnings Yield

-3.00%

Dividend Yield

5.12%

Payout Ratio

-1.77%

Stock Overview

Market Cap

$1.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

367.10M

Volume

11.11K

Avg. Volume

3.12K

Financials (TTM)

Gross Profit

SEK 6.19B

Operating Income

SEK 855.70M

EBITDA

SEK 1.87B

Operating Cash Flow

SEK 2.44B

Capital Expenditure

-SEK 624.59M

Free Cash Flow

SEK 1.82B

Cash & ST Invst.

SEK 3.17B

Total Debt

SEK 7.30B

Elekta Ab (publ) Performance Analysis

Elekta Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-04-30SEK 1,614,476,247-1.2%
20242024-04-30SEK 1,702,409,8715.4%
20252025-04-30SEK 1,706,628,4650.2%
20262026-04-30SEK 1,780,004,6264.3%
Elekta Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-31-29.3%
Q22025-10-3111.6%
Q32026-01-31-0.2%
Q42026-04-3017.4%
Elekta Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-04-30SEK 0.24-30.5%
20242024-04-30SEK 0.3235.7%
20252025-04-30SEK 0.06-81.6%
20262026-04-30SEK -0.14N/A
Elekta Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-31127.7%
Q22025-10-31114.3%
Q32026-01-31-95.8%
Q42026-04-30-9300.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

SEK 4.77B

-7.5%

Gross Profit

SEK 1.89B

-8.2%

Gross Margin

39.52%

N/A

Market Cap

$1.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$408.17K

N/A

Employees

4,541

N/A

Net Income

-SEK 867.62M

-124.8%

EBITDA

SEK 69.13M

-44.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

SEK 3.17B

+7.4%

Total Debt

SEK 7.30B

-3.6%

Accounts Receivable

SEK 7.00B

-9.1%

Inventory

SEK 2.86B

+3.8%

Long Term Debt

SEK 4.12B

-42.5%

Short Term Debt

SEK 3.19B

+676.9%

Return on Assets

-1.93%

N/A

Return on Invested Capital

7.44%

N/A

Free Cash Flow

SEK 1.36B

+8.6%

Operating Cash Flow

SEK 1.39B

-11.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RTEZRest Ez Inc.
$70.00+0.00%
GENSFGenus plc
$31.07+0.00%
BOEUFBonesupport Holding AB (publ)
$20.49+0.00%
VTRLYVitrolife AB (publ)
$9.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About EKTAY

What is the current price of Elekta Ab (publ)?

Elekta Ab (publ) is trading at $5.05 per share.

What is the 52-week range for Elekta Ab (publ)?

Over the past 52 weeks, Elekta Ab (publ) has traded between $4.35 and $6.93.

How much debt does Elekta Ab (publ) have?

As of the most recent reporting period, Elekta Ab (publ) reported total debt of SEK 792.38M.

How much cash does Elekta Ab (publ) have on hand?

Elekta Ab (publ) reported SEK 344.69M in cash and cash equivalents in its most recent financial results.

What is Elekta Ab (publ)’s dividend yield?

Elekta Ab (publ) currently has a dividend yield of 5.12%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services